Full View

Targetable kinase gene fusions in high-risk B-ALL: a study from the Children's Oncology Group

SC Reshmi, RC Harvey, KG Roberts… - Blood, The Journal …, 2017 - ashpublications.org
Philadelphia chromosome-like (Ph-like) acute lymphoblastic leukemia (ALL) is a high-risk
subtype characterized by genomic alterations that activate cytokine receptor and kinase …
被引用次数：300 相关文章

[引用][C] Targetable kinase gene fusions in high-risk B-ALL: a study from the Children's Oncology Group.

SC Reshmi, RC Harvey, KG Roberts, E Stonerock… - …, 2017 - hsrc.himmelfarb.gwu.edu
"Targetable kinase gene fusions in high-risk B-ALL: a study from the Ch" by Shalini C
Reshmi, Richard C Harvey et al. Home Search Browse Collections My Account About DC …

Targetable kinase gene fusions in high-risk B-ALL: A study from the Children's Oncology Group

SC Reshmi, RC Harvey, KG Roberts… - …, 2017 - mdanderson.elsevierpure.com
Abstract Philadelphiachromosome-like (Ph-like) acutelymphoblasticleukemia (ALL) isahigh-
risk subtype characterized by genomic alterations that activate cytokine receptor and kinase …

Targetable kinase gene fusions in high-risk B-ALL: a study from the Children's Oncology Group

SC Reshmi, RC Harvey, KG Roberts, E Stonerock… - …, 2017 - pubmed.ncbi.nlm.nih.gov
Philadelphia chromosome-like (Ph-like) acute lymphoblastic leukemia (ALL) is a high-risk
subtype characterized by genomic alterations that activate cytokine receptor and kinase …
[HTML] sciencedirect.com

[HTML][HTML] Targetable kinase gene fusions in high-risk B-ALL: a study from the Children's Oncology Group

SC Reshmi, RC Harvey, KG Roberts, E Stonerock… - Blood, 2017 - Elsevier
Philadelphia chromosome-like (Ph-like) acute lymphoblastic leukemia (ALL) is a high-risk
subtype characterized by genomic alterations that activate cytokine receptor and kinase …

Targetable kinase gene fusions in high-risk B-ALL: A study from the Children's Oncology Group

SC Reshmi, RC Harvey, KG Roberts… - …, 2017 - ohiostate.elsevierpure.com
Abstract Philadelphiachromosome-like (Ph-like) acutelymphoblasticleukemia (ALL) isahigh-
risk subtype characterized by genomic alterations that activate cytokine receptor and kinase …

Targetable kinase gene fusions in high-risk B-ALL: a study from the Children's Oncology Group.

SC Reshmi, RC Harvey, KG Roberts, E Stonerock… - Blood, 2017 - europepmc.org
Philadelphia chromosome-like (Ph-like) acute lymphoblastic leukemia (ALL) is a high-risk
subtype characterized by genomic alterations that activate cytokine receptor and kinase …

Targetable kinase gene fusions in high-risk B-ALL: A study from the Children's Oncology Group

SC Reshmi, RC Harvey, KG Roberts, E Stonerock… - Blood, 2017 - pure.johnshopkins.edu
Abstract Philadelphiachromosome-like (Ph-like) acutelymphoblasticleukemia (ALL) isahigh-
risk subtype characterized by genomic alterations that activate cytokine receptor and kinase …
[HTML] nih.gov

[HTML][HTML] Targetable kinase gene fusions in high-risk B-ALL: a study from the Children's Oncology Group

SC Reshmi, RC Harvey, KG Roberts, E Stonerock… - Blood, 2017 - ncbi.nlm.nih.gov
Philadelphia chromosome-like (Ph-like) acute lymphoblastic leukemia (ALL) is a high-risk
subtype characterized by genomic alterations that activate cytokine receptor and kinase …

Targetable kinase gene fusions in high-risk B-ALL: A study from the Children's Oncology Group

SC Reshmi, RC Harvey, KG Roberts… - …, 2017 - mayoclinic.elsevierpure.com
Abstract Philadelphiachromosome-like (Ph-like) acutelymphoblasticleukemia (ALL) isahigh-
risk subtype characterized by genomic alterations that activate cytokine receptor and kinase …